Cargando…

Characterization of oncogenic pathways linked with T cell exclusion in urothelial bladder cancer

Detalles Bibliográficos
Autores principales:	Sweis, Randy F, Spranger, Stefani, Luke, Jason J, Gajewski, Thomas F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645501/ http://dx.doi.org/10.1186/2051-1426-3-S2-O14

Ejemplares similares

Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment
por: Spranger, Stefani, et al.
Publicado: (2013)

Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment
por: Horton, Brendan, et al.
Publicado: (2015)

Melanoma-intrinsic β-catenin signaling prevents T cell infiltration and anti-tumor immunity
por: Spranger, Stefani, et al.
Publicado: (2014)

Tumor-intrinsic oncogene pathways mediating immune avoidance
por: Spranger, Stefani, et al.
Publicado: (2015)

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
por: Sweis, Randy F., et al.
Publicado: (2018)

A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
por: Spranger, Stefani, et al.
Publicado: (2015)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
por: Kacew, Alec, et al.
Publicado: (2020)

The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors
por: Luke, Jason J, et al.
Publicado: (2015)

Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling
por: Spranger, Stefani, et al.
Publicado: (2015)

Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors
por: Horton, Brendan, et al.
Publicado: (2014)

Oncogenic switching of hypoxia signalling pathways
por: Ratcliffe, Peter J
Publicado: (2014)

Rational combinations of immunotherapeutics that target discrete pathways
por: Spranger, Stefani, et al.
Publicado: (2013)

Innate immune sensing of a growing tumor in vivo occurs via the host sting pathway and involves mitochondrial DNA transfer from cancer cells to DCs
por: Woo, Seng-Ryong, et al.
Publicado: (2013)

Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
por: Zha, Yuanyuan, et al.
Publicado: (2015)

Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo
por: Corrales, Leticia, et al.
Publicado: (2013)

Effect of smoking on urothelial cancer risk in individuals with Lynch syndrome
por: Kohlmann, Wendy, et al.
Publicado: (2010)

Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers
por: Gangadhar, Tara C, et al.
Publicado: (2015)

Evidence implicating the commensal microbiota in shaping anti-tumor immunity in melanoma
por: Sivan, Ayelet, et al.
Publicado: (2014)

Characterizing the role of the alternative NF-κB pathway in diffuse large B-cell lymphoma
por: Ito, Daisuke, et al.
Publicado: (2013)

Injury prevention and performance – are they mutually exclusive? What does science tell us?
por: McGregor, Alison
Publicado: (2015)

Multiple giant coronary aneurysms in adult patient managed by exclusion with bypass, case report
por: Jaber, S, et al.
Publicado: (2013)

S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity
por: Kaur, Rupinder
Publicado: (2022)

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
por: Trujillo, Jonathan A., et al.
Publicado: (2019)

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAF(V600)- mutated melanoma (BRIM7)
por: Puzanov, Igor, et al.
Publicado: (2014)

Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
por: Nguyen, Kim Bich, et al.
Publicado: (2019)

Fructose-2,6-bisphosphate links glucose to survival and growth
por: Yalcin, Abdullah, et al.
Publicado: (2014)

AMPK regulated metabolic programing: oncogenic or growth suppressive? Evolving lessons from genetic and pharmacologic studies
por: Liu, Xiaona, et al.
Publicado: (2014)

Total arterial revascularization on OPCABG with the exclusive use of two internal mammary arteries – a single center ten-year study analysis
por: Prapas, S, et al.
Publicado: (2013)

Efficacy of anti-ICOS agonist monoclonal antibodies in preclinical tumor models provides a rationale for clinical development as cancer immunotherapeutics
por: Harvey, Christopher, et al.
Publicado: (2015)

A Drosophila model linking diet-induced metabolic disease and cancer
por: Hirabayashi, Susumu, et al.
Publicado: (2014)

Management of neurogenic bladder in myelodysplasia patients: experience at our center
por: Singh, Sangram, et al.
Publicado: (2010)

O6 Reshaping the diagnostic pathways for investigation of haematuria during and after the COVID-19 pandemic: Diagnostic accuracy of strategies for the detection of bladder cancer from the IDENTIFY cohort study
por: Khadhouri, Sinan, et al.
Publicado: (2021)

The HTLV-1 encoded bZIP factor promotes cell proliferation and genetic instability through activation of oncogenic microRNAs
por: Vernin, Céline, et al.
Publicado: (2014)

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma
por: Yan, Yibing, et al.
Publicado: (2014)

Coercive treatment and stigma: is there a link?
por: Gaebel, Wolfgang
Publicado: (2007)

Is leptin the link between obesity and osteoarthritis?
por: Pottie, P, et al.
Publicado: (2004)

Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)

Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review
por: Walia, Arman S., et al.
Publicado: (2021)

The role of bladder neck repairs in the management of urinary incontinence in spina bifida patients
por: Karmarkar, Santosh, et al.
Publicado: (2006)

Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity
por: Corrales, Leticia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_id4jva9kmhl0a8hbcp32oco9o6